PMID- 30141626 OWN - NLM STAT- MEDLINE DCOM- 20190726 LR - 20200309 IS - 1554-8937 (Electronic) IS - 1554-8929 (Print) IS - 1554-8929 (Linking) VI - 13 IP - 10 DP - 2018 Oct 19 TI - A Chemical Biology Approach to Model Pontocerebellar Hypoplasia Type 1B (PCH1B). PG - 3000-3010 LID - 10.1021/acschembio.8b00745 [doi] AB - Mutations of EXOSC3 have been linked to the rare neurological disorder known as Pontocerebellar Hypoplasia type 1B (PCH1B). EXOSC3 is one of three putative RNA-binding structural cap proteins that guide RNA into the RNA exosome, the cellular machinery that degrades RNA. Using RNAcompete, we identified a G-rich RNA motif binding to EXOSC3. Surface plasmon resonance (SPR) and microscale thermophoresis (MST) indicated an affinity in the low micromolar range of EXOSC3 for long and short G-rich RNA sequences. Although several PCH1B-causing mutations in EXOSC3 did not engage a specific RNA motif as shown by RNAcompete, they exhibited lower binding affinity to G-rich RNA as demonstrated by MST. To test the hypothesis that modification of the RNA-protein interface in EXOSC3 mutants may be phenocopied by small molecules, we performed an in-silico screen of 50 000 small molecules and used enzyme-linked immunosorbant assays (ELISAs) and MST to assess the ability of the molecules to inhibit RNA-binding by EXOSC3. We identified a small molecule, EXOSC3-RNA disrupting (ERD) compound 3 (ERD03), which ( i) bound specifically to EXOSC3 in saturation transfer difference nuclear magnetic resonance (STD-NMR), ( ii) disrupted the EXOSC3-RNA interaction in a concentration-dependent manner, and ( iii) produced a PCH1B-like phenotype with a 50% reduction in the cerebellum and an abnormally curved spine in zebrafish embryos. This compound also induced modification of zebrafish RNA expression levels similar to that observed with a morpholino against EXOSC3. To our knowledge, this is the first example of a small molecule obtained by rational design that models the abnormal developmental effects of a neurodegenerative disease in a whole organism. FAU - Francois-Moutal, Liberty AU - Francois-Moutal L AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. AD - Center for Innovation in Brain Science , Tucson , Arizona 85721 , United States. FAU - Jahanbakhsh, Shahriyar AU - Jahanbakhsh S AD - Department of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States. FAU - Nelson, Andrew D L AU - Nelson ADL AUID- ORCID: 0000-0001-9896-1739 AD - School of Plant Sciences , University of Arizona , Tucson , Arizona 85721 , United States. FAU - Ray, Debashish AU - Ray D AD - Donnelly Centre , University of Toronto , Toronto , Canada M5S 3E1. FAU - Scott, David D AU - Scott DD AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. AD - Center for Innovation in Brain Science , Tucson , Arizona 85721 , United States. FAU - Hennefarth, Matthew R AU - Hennefarth MR AD - Department of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States. FAU - Moutal, Aubin AU - Moutal A AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. FAU - Perez-Miller, Samantha AU - Perez-Miller S AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. AD - Center for Innovation in Brain Science , Tucson , Arizona 85721 , United States. FAU - Ambrose, Andrew J AU - Ambrose AJ AUID- ORCID: 0000-0002-2932-4514 AD - Pharmacology and Toxicology, School of Pharmacy , University of Arizona , Tucson , Arizona 85724 , United States. FAU - Al-Shamari, Ahmed AU - Al-Shamari A AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. FAU - Coursodon, Philippe AU - Coursodon P AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. FAU - Meechoovet, Bessie AU - Meechoovet B AD - Neurogenomics Division , TGen , Phoenix , Arizona 85004 , United States. FAU - Reiman, Rebecca AU - Reiman R AD - Neurogenomics Division , TGen , Phoenix , Arizona 85004 , United States. FAU - Lyons, Eric AU - Lyons E AD - School of Plant Sciences , University of Arizona , Tucson , Arizona 85721 , United States. FAU - Beilstein, Mark AU - Beilstein M AD - School of Plant Sciences , University of Arizona , Tucson , Arizona 85721 , United States. FAU - Chapman, Eli AU - Chapman E AD - Pharmacology and Toxicology, School of Pharmacy , University of Arizona , Tucson , Arizona 85724 , United States. FAU - Morris, Quaid D AU - Morris QD AD - Donnelly Centre , University of Toronto , Toronto , Canada M5S 3E1. AD - Department of Molecular Genetics , University of Toronto , Toronto , Canada M5S 1A8. AD - Department of Computer Science , University of Toronto , Toronto , Canada M5S 2E4. AD - Department of Electrical and Computer Engineering , University of Toronto , Toronto , Canada M5S3G4. FAU - Van Keuren-Jensen, Kendall AU - Van Keuren-Jensen K AD - Neurogenomics Division , TGen , Phoenix , Arizona 85004 , United States. FAU - Hughes, Timothy R AU - Hughes TR AD - Donnelly Centre , University of Toronto , Toronto , Canada M5S 3E1. AD - Department of Molecular Genetics , University of Toronto , Toronto , Canada M5S 1A8. FAU - Khanna, Rajesh AU - Khanna R AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. AD - Center for Innovation in Brain Science , Tucson , Arizona 85721 , United States. FAU - Koehler, Carla AU - Koehler C AD - Department of Chemistry and Biochemistry , University of California , Los Angeles , California 90095 , United States. FAU - Jen, Joanna AU - Jen J AD - Mount Sinai , New York , New York 10029 , United States. FAU - Gokhale, Vijay AU - Gokhale V AD - Bio5 Institute , University of Arizona , Tucson , Arizona , United States. FAU - Khanna, May AU - Khanna M AUID- ORCID: 0000-0002-9989-6374 AD - Department of Pharmacology , College of Medicine, University of Arizona , Tucson , Arizona 85724 , United States. AD - Center for Innovation in Brain Science , Tucson , Arizona 85721 , United States. LA - eng GR - R01 GM061721/GM/NIGMS NIH HHS/United States GR - R01 HG008613/HG/NHGRI NIH HHS/United States GR - T32 GM008804/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20180906 PL - United States TA - ACS Chem Biol JT - ACS chemical biology JID - 101282906 RN - 0 (EXOSC3 protein, human) RN - 0 (Isoquinolines) RN - 0 (RNA-Binding Proteins) RN - 63231-63-0 (RNA) RN - EC 3.1.- (Exosome Multienzyme Ribonuclease Complex) RN - Pontocerebellar Hypoplasia Type 1 MH - Animals MH - Atrophy MH - Cerebellum/pathology MH - *Disease Models, Animal MH - Down-Regulation MH - Exosome Multienzyme Ribonuclease Complex/chemistry/genetics/*metabolism MH - Gene Knockdown Techniques MH - Humans MH - Isoquinolines/metabolism/*pharmacology/*toxicity MH - Molecular Docking Simulation MH - Mutation MH - Olivopontocerebellar Atrophies/chemically induced/*genetics/pathology MH - Phenotype MH - Protein Binding MH - Protein Domains MH - RNA/*metabolism MH - RNA-Binding Proteins/chemistry/genetics/*metabolism MH - Spinal Curvatures/chemically induced MH - Transcriptome/drug effects MH - Up-Regulation MH - Zebrafish/*abnormalities PMC - PMC6504997 MID - NIHMS1016684 COIS- The authors declare no competing financial interest. EDAT- 2018/08/25 06:00 MHDA- 2019/07/28 06:00 PMCR- 2019/05/08 CRDT- 2018/08/25 06:00 PHST- 2018/08/25 06:00 [pubmed] PHST- 2019/07/28 06:00 [medline] PHST- 2018/08/25 06:00 [entrez] PHST- 2019/05/08 00:00 [pmc-release] AID - 10.1021/acschembio.8b00745 [doi] PST - ppublish SO - ACS Chem Biol. 2018 Oct 19;13(10):3000-3010. doi: 10.1021/acschembio.8b00745. Epub 2018 Sep 6.